D-Optimal Design and Development of a Koumine-Loaded Microemulsion for Rheumatoid Arthritis Treatment: In vivo and in vitro Evaluation
International Journal of Nanomedicine · 2023-06 · Volume 18 · 2973-2988
DOI: 10.2147/ijn.s406641 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023-06. Verfasst von Qing Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Koumine (KME) is the most abundant active ingredient separated from Gelsemium elegans Benth and exhibits a significant therapeutic effect on rheumatoid arthritis (RA). It is a lipophilic compound with poor aqueous solubility, and there is an urgent need to develop novel dosage forms of KME and promote its clinical application for the treatment of RA. The aim of this study was to design and develop KME-loaded microemulsions (KME-MEs) for the effective management of RA.
Methods
The composition of the microemulsion was selected by carrying out a solubility study and generating pseudoternary phase diagrams, and further optimized by D-Optimal design. The optimized KME-MEs was evaluated for particle size, viscosity, drug release, storage stability, cytotoxicity, cellular uptake, Caco-2 cell transport and everted gut sac investigations. In vivo fluorescence imaging and the therapeutic effects of KME and KME-MEs on collagen-induced arthritis (CIA) rats were also evaluated.
Results
The optimized microemulsion contained 8% oil, 32% Smix (surfactant/cosurfactant) and 60% water and was used for in vivo and in vitro studies. The optimal KME-MEs exhibited a small globule size of 18.5 ± 0.14 nm and good stability over 3 months, and the release kinetics followed a first-order model. These KME-MEs had no toxic effect on Caco-2 cells but were efficiently internalized into the cytoplasm. Compared to KME, the KME-MEs displayed significantly increased permeability and absorption in Caco-2 cell monolayer assay and ex vivo everted gut sac experiment. As expected, the KME-MEs attenuated the progression of RA in CIA rats and were more effective than free KME with a reduced frequency of administration.
Conclusion
The KME-MEs improved the solubility and therapeutic efficacy of KME by employing formulation technology. These results provide a promising vehicle for the oral delivery of KME to treat RA and have attractive potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China.
- Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China.
Zitieren
APA
Hu, Q., Fu, X. L., Dong, Y. Y., Ma, J., Hua, J., Li, J. T., Liu, K. X., Yang, J., & Yu, C. X. (2023). D-Optimal Design and Development of a Koumine-Loaded Microemulsion for Rheumatoid Arthritis Treatment: In vivo and in vitro Evaluation. International Journal of Nanomedicine, Volume 18, 2973-2988. https://doi.org/10.2147/ijn.s406641
Vancouver
Hu Q, Fu XL, Dong YY, Ma J, Hua J, Li JT, et al. D-Optimal Design and Development of a Koumine-Loaded Microemulsion for Rheumatoid Arthritis Treatment: In vivo and in vitro Evaluation. International Journal of Nanomedicine. 2023;Volume 18:2973-2988. doi:10.2147/ijn.s406641
BibTeX
@article{Hu2023,
author = {Hu, Qing and Fu, Xiao-Ling and Dong, Yi-Yan and Ma, Ju and Hua, Jian and Li, Jia-Ting and Liu, Kai-Xin and Yang, Jian and Yu, Chang-Xi},
title = {D-Optimal Design and Development of a Koumine-Loaded Microemulsion for Rheumatoid Arthritis Treatment: In vivo and in vitro Evaluation},
journal = {International Journal of Nanomedicine},
year = {2023},
volume = {Volume 18},
pages = {2973--2988},
doi = {10.2147/ijn.s406641}
}
EUVIMED